David-Alexandre C. Gros - Jun 9, 2021 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Chief Executive Officer, Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for David-Alexandre Gros
Stock symbol
ELDN
Transactions as of
Jun 9, 2021
Transactions value $
$24,030
Form type
4
Date filed
6/10/2021, 05:25 PM
Next filing
Aug 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELDN Common Stock Purchase $24K +3K $8.01* 3K Jun 9, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 reports an open market purchase by the Reporting Person of shares of common stock in accordance with the Issuer's trading policies.